Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and tolerability of ilaprazole relative to
that of esomeprazole in healing erosive esophagitis and resolving accompanying symptoms of
GERD.